
Should Patients With Cancer Receive mRNA Vaccines Alongside Immunotherapy?
About this episode
A recent study found a link between mRNA vaccination and improved cancer immunotherapy response. The preclinical data demonstrated impressive results, leading to big questions.
“We believe that [vaccination] actually does generate and even converts the cold tumors to hot tumors,” Steven H. Lin, MD, PhD, a physician-scientist and radiation oncologist at the University of Texas MD Anderson Cancer Center in Houston, tells Robert A. Figlin, MD, the interim director of Cedars-Sinai Cancer Center in Los Angeles and Steven Spielberg Family Chair in Hematology-Oncology.
Get every episode summarized
Each time Oncology News Central Peer-Spectives publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Oncology News Central Peer-Spectives

Advances in ESR1-Mutated Breast Cancer Care Lead to “Complex Situation” in Clini...
Oncology News Central Peer-Spectives

Tackling “the Biggest Question That Everyone Is Asking” in Breast Cancer Care
Oncology News Central Peer-Spectives

Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC
Oncology News Central Peer-Spectives

“Where the Real Answer Lies”: How CNS Disease Influences EGFR-Mutated NSCLC Trea...
Oncology News Central Peer-Spectives